Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Hepatology. 2023 Feb 17;77(3):997–1005. doi: 10.1002/hep.32434

Table 2.

HCC incidence overall and in key subgroups defined based on etiology and race/ethnicity.

Frequency of patients Frequency of patients with HCC Person-years (PY) follow up HCC Incidence per 100 PY 95% Confidence Interval
Overall 2733 135 7418 1.82 1.51–2.13
Etiology 1
Active hepatitis C virus (HCV)1 521 55 1636 3.36 2.47–4.25
Cured HCV 638 33 1927 1.71 1.13–2.30
Alcohol related liver disease 439 15 1133 1.32 0.65–1.99
Nonalcoholic fatty liver disease 822 24 1940 1.24 0.74–1.73
Hepatitis B virus infection2 67 4 209 1.91 0.04–3.78
Autoimmune hepatitis 117 4 305 1.31 0.03–2.60
Primary biliary cirrhosis 75 0 176 0.00 0.00–0.00
Primary sclerosing cholangitis 22 0 56 0.00 0.00–0.00
Other etiologies2 81 2 179 1.12 0.00–2.68
Missing 10 1 45 2.24 0.00–6.64
Race/ethnicity
Non-Hispanic White 1373 72 3711 1.94 1.49–2.38
Hispanics 748 31 1879 1.65 1.07–2.23
Non-Hispanic Black 533 28 1618 1.73 1.09–2.38
1

HCV status was defined based on data at the time of cohort enrollment.

2

Only, 32 patients had HBV infection without other risk factors, with an annual HCC incidence rate of 1.13% (95% CI, 0.00, 3.35%).

See footnote for Table 1.